BIGBEAR
PHARMACEUTICAL
Ixazomib is a targeted anticancer drug that controls cancer cell growth by reversibly inhibiting the function of the proteasome.
AuthenticGuaranteeFast DeliveryPrivacy Ixazomib is a proteasome inhibitor used to treat multiple myeloma and is a prescription drug. Its price is significantly affected by dosage, region, m···【More】
Update: 26 Mar,2026Source: BigbearViews: 114
Ixazomib (generic name) is a prescription drug used to treat multiple myeloma. The price varies depending on dosage, strength, region, and purchase ch···【More】
Update: 26 Mar,2026Source: BigbearViews: 99
Ixazomib, a novel targeted therapy drug, inhibits the activity of the proteasome, blocking the growth and proliferation of tumor cells, providing an i···【More】
Update: 13 Mar,2026Source: BigbearViews: 99
Ixazomib is an oral proteasome inhibitor primarily used in the clinical treatment of multiple myeloma. As a novel targeted therapy, it blocks the grow···【More】
Update: 13 Mar,2026Source: BigbearViews: 98
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
